Novel COX-2 Inhibitor for Breast Cancer Therapy

doi 10.21236/ada420352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Novel Thioredoxin Inhibitors for Breast Cancer Therapy

2002English

Novel Thioredoxin Inhibitors for Breast Cancer Therapy

2001English

COX-2 Involvement in Breast Cancer Metastasis to Bone

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines

Journal of Surgical Research
Surgery
2010English

Expression of COX-2 and Steroid Converting Enzymes in Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2006English

Inducible COX-2 Dominates Over COX-1 in Prostacyclin Biosynthesis: Mechanisms of COX-2 Inhibitor Risk to Heart Disease

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2011English

The Novel mTORC1/2 Dual Inhibitor INK128 Enhances Radiosensitivity of Breast Cancer Cell Line McF-7

International Journal of Oncology
Cancer ResearchOncology
2016English

HPV16 E7 Increases COX‑2 Expression and Promotes the Proliferation of Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy